Quantcast

Latest Ondine Biomedical Inc. Stories

2014-09-15 23:01:28

Ondine's President and Chief Technology Officer Dr. Nicolas Loebel will be presenting at the 10th International Symposium on Photodynamic Therapy & Photodiagnosis in Clinical Practice Vancouver, BC (PRWEB) September 15, 2014 Ondine Biomedical Inc. is pleased to announce that Dr. Nicolas Loebel, its President and Chief Technology Officer, will be presenting at the 10th International Symposium on Photodynamic Therapy (PDT) and Photodiagnosis in Clinical Practice. The 2014 Symposium,...

2014-09-04 23:10:55

Significant Surgical Site Infection Reduction Demonstrated Vancouver, Canada (PRWEB) September 04, 2014 Results of the first large-scale deployment of Ondine Biomedical’s MRSAid™ Nasal Photodisinfection System demonstrating reduction of surgical site infection rates have been published in the Journal of Hospital Infection (http://www.journalofhospitalinfection.com/article/S0195-6701(14)00224-2/abstract ).    The system was deployed at The Vancouver General...

2013-11-21 23:30:18

Ondine Biomedical is pleased to announce that a second hospital, Abbotsford Hospital in British Columbia Canada, will be implementing its MRSAid Nasal Decolonization System in order to reduce the rate of surgical site infections. Vancouver, British Columbia (PRWEB) November 21, 2013 Ondine Biomedical Inc. is pleased to announce that a second hospital in British Columbia, Canada will be implementing its MRSAid™ Nasal Decolonization System in order to reduce the rate of surgical site...

2013-09-17 23:32:27

UCL is the research partner of Ondine Biomedical Inc., the global leader in developing Photodisinfection (aPDT) based technologies and applications. Ondine is focused on Health Care Associated Infection (HAI) prevention products as well as therapies such as the MRSAid Photodisinfection System. (PRWEB) September 17, 2013 Ondine is pleased to announce that Sacha Noimark, Elaine Allan and Ivan Parkin were presented with the ‘Best Poster’ recognition at the EuCheMS Inorganic Chemistry...

2013-09-05 23:25:45

MRSAid™ was recently featured in the 2013 ICPIC (International Consortium for Prevention & Infection Control) Innovation Award received by the Vancouver General Hospital infection control team lead by Dr. Elizabeth Bryce. The VGH team was the winner of this prestigious global recognition for pioneering a novel universal decolonization protocol involving Ondine’s Photodisinfection technology, MRSAid. Vancouver, British Columbia (PRWEB) September 05, 2013 Ondine Biomedical Inc. is...

2013-07-17 23:24:26

Ondine Biomedical Inc. announces that the Vancouver General Hospital (VGH), the first hospital to deploy its MRSAid™ Photodisinfection system, was selected as the recipient of the Innovation Award at the 2013 International Consortium for Prevention & Infection Control (ICPIC). Endorsed by the World Health Organization (WHO), ICPIC is a prestigious international conference that brings together more than 1,200 leaders in infection control from 84 countries. Vancouver, British Columbia...

2013-06-06 23:23:43

Ondine Biomedical congratulates Dr. Marta Segarra Vidal for her recent Oral Communications of Research award at the SEPA conference (Spanish Society of Periodentists). This recognition relates to Dr. Vidal´s work with photodisinfection and Periowave at the University of Valencia, where this technology has been deployed for the past few years. Vancouver, British Columbia (PRWEB) June 06, 2013 Ondine Biomedical Inc. congratulates Dr. Marta Segarra Vidal for her recent Oral Communications...

2012-02-28 17:55:00

Ondine Biomedical Inc. announces today that its MRSAid Photodisinfection System for nasal pathogen decolonization has successfully treated over 2,500 patients since April 2011 as a part of an infection control Quality Improvement Project being conducted at Vancouver General Hospital. This project, championed by Dr. Elizabeth Bryce, Regional Medical Director, Infection Control, Vancouver Coastal Health, is being undertaken with the objective of reducing the incidence of surgical site...

2011-06-07 00:00:33

"These abstracts clearly confirm a role of PDT in the treatment of head and neck cancer. The inclusion of our abstracts in this year's IPA's World Congress 2011 is an important accomplishment for our Company as it reflects the high quality of research and the IPA's interest in our technology," said Carolyn Cross, Chairman & CEO of Ondine Biomedical Inc. Vancouver, British Columbia (PRWEB) June 06, 2011 Ondine Biomedical Inc (TSX: OBP; AIM: OBP; the "Company"), is dedicated to the...

2011-05-13 00:00:30

"We have spent the last 70 years using and misusing antibiotics to treat and prevent common infectious diseases" stated Carolyn Cross. "Today, we have entered an era where many bacteria have developed resistance to most antibiotics, rendering many of these drugs almost useless. It is therefore imperative that non-antibiotic solutions to fight infections are developed in order to preserve the next generation of effective medicine." Ms. Cross will assist the IPA in raising awareness about the...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related